Neurobiol Dis. 2019 Jan 24. pii: S0969-9961(18)30685-5. doi: 10.1016/j.nbd.2019.01.014.
[Epub ahead of print]
Navarro-Romero A1, Vázquez-Oliver A1, Gomis-González M1, Garzón-Montesinos C2, Falcón-Moya R2, Pastor A3, Martín-García E4, Pizarro N5, Busquets-Garcia A1, Revest JM6, Piazza PV6, Bosch F7, Dierssen M8, de la Torre R3, Rodríguez-Moreno A2, Maldonado R1, Ozaita A9.
Abstract
![](https://freedomwares.ca/wp-content/uploads/2017/07/PM-2-site-207-e1499843845531.jpg)
Copyright © 2019. Published by Elsevier Inc.
KEYWORDS:
Cannabinoid receptor type-1; Cognitive deficits; Down syndrome; Endocannabinoid system; Hippocampus; Intellectual disability
- PMID: 30685352
- DOI: 10.1016/j.nbd.2019.01.014